FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used in therapy. Method for diagnosing a comatose state in pneumonia involves examining a general clinical condition of a patient and a pulmonary tissue prior to treatment by computed tomography, spirography with simultaneous general analysis, wherein blood serum is additionally determined by amount of C-reactive protein, level of TBA-active compounds, activity of catalase, superoxide dismutase, elastase- and trypsin-like proteinases when compared with the control, the discriminant functions Y1 and Y2 are calculated by equations: Y1=-28.8+0.4⋅X1+0.1⋅X2-0.01⋅X3+0.01⋅X4+3.8⋅X5; Y2=-31.0+0.1⋅X1-0.01⋅X2+0.1⋅X3+0.2⋅X4-0.6⋅X5; where X1 is the amount of C-reactive protein, mg/l; X2 – activity of trypsin-like proteinases, nmol BAEE/min⋅ml; X3 – activity of elastase-like proteinases, nmole BANE/min⋅ml; X4 is catalase activity, mcmol/l; X5 – activity of superoxide dismutase, unit/l, and if Y1 value is more than Y2 with ESR growth by 7 times and more as compared to norm (7.6±2.0) mm Hg, increase in amount of C-reactive protein by 100 times and more at norm (0.6±0.07) mg/l, increased level of TBA-active compounds by 4 times and more at norm (3.1±0.4) mc/ml on the background of sharply expressed eosinophilia exceeding norm by 10 times and more at norm (2.4±0.6) %, comatose state is diagnosed in pneumonia with alveolar type of infiltration in pulmonary tissue.
EFFECT: invention provides higher accuracy and effectiveness of diagnosing coma.
1 cl, 4 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EVALUATING EFFECTIVENESS OF TREATMENT OF PNEUMONIA | 2020 |
|
RU2753746C1 |
METHOD FOR EVALUATING EFFECTIVENESS OF TREATMENT OF PNEUMONIA | 2020 |
|
RU2753744C1 |
METHOD FOR PREDICTING COURSE OF PNEUMONIA WITH ALVEOLAR TYPE OF LUNG TISSUE INFILTRATION | 2020 |
|
RU2753745C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF PULMONARY TISSUE INFILTRATION TYPE IN PNEUMONIA | 2020 |
|
RU2738450C1 |
METHOD FOR DETECTING MICROCIRCULATORY DISORDERS AS A BIOMARKER OF INTERSTITIAL CHANGES IN THE LUNGS OF PATIENTS UNDERGONE A NEW CORONAVIRUS INFECTION | 2022 |
|
RU2790513C1 |
METHOD FOR EARLY DIFFERENTIAL DIAGNOSIS OF VIRAL AND BACTERIAL COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN | 2022 |
|
RU2790239C1 |
METHOD FOR PREDICTING OUTCOME OF INFECTIOUS PROCESS AFTER A NEW CORONAVIRUS INFECTION FOR 12 MONTHS | 2023 |
|
RU2807384C1 |
METHOD FOR PREDICTION OF PROBABILITY OF POSSIBLE EXECUTION OF OPTIMUM CYTOREDUCTIVE OPERATION IN PATIENTS WITH DISSEMINATED FORMS OF OVARIAN CANCER | 2017 |
|
RU2637399C1 |
METHOD FOR DISTANT METASTASES DEVELOPMENT RISK DEGREE DETERMINATION FOR PATIENTS WITH COLON CANCER | 2016 |
|
RU2623119C1 |
METHOD FOR EVALUATING THE DEGREE OF RISK OF ADVERSE EVALUATION OF DISEASE IN PATIENTS WITH GASTRIC CANCER | 2016 |
|
RU2662085C1 |
Authors
Dates
2020-12-14—Published
2020-06-16—Filed